BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 97392)

  • 21. The kinetics of Cr release from target cells in cell mediated cytotoxicity and the relationship to the kinetics of killing.
    Sanderson CJ; Taylor GA
    Cell Tissue Kinet; 1975 Jan; 8(1):23-32. PubMed ID: 803411
    [No Abstract]   [Full Text] [Related]  

  • 22. Single and dual labelling of cytotoxic target cells. Comparison of three radioactive tracers, [35S]methionine, [75Se]selenomethionine, and chromium-51.
    Heymer J; Leibold W
    J Immunol Methods; 1993 May; 161(2):217-22. PubMed ID: 8505550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. I. Basic parameters: baseline controls, target cells, and methods of calculation.
    Ting CC; Park JY; Nunn ME; Herberman RB
    J Natl Cancer Inst; 1977 Feb; 58(2):323-30. PubMed ID: 833880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A microcytotoxicity assay using 111indium oxine release from platelets.
    Hawker RJ; Hawker LM
    J Immunol Methods; 1980; 33(1):45-53. PubMed ID: 7358998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. II. Sensitivity and specificity of the assays and characteristics of effector and sensitizing cells.
    Ting CC; Nunn ME; Park JY; Herberman RB
    J Natl Cancer Inst; 1977 Feb; 58(2):331-7. PubMed ID: 833881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of the 51Cr release cytotoxicity assay for cytotoxic lymphocytes.
    Miller RG; Dunkley M
    Cell Immunol; 1974 Nov; 14(2):284-302. PubMed ID: 4219591
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune responses in human colon cancer. I. Microcytotoxicity assay for measuring killing of adherent human colon cancer cell lines.
    Hahn WV; Kagnoff MF; Hatlen LE; Austin RK
    Gastroenterology; 1978 Nov; 75(5):800-5. PubMed ID: 700323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse.
    Wolf JE; Faanes RB; Choi YS
    J Natl Cancer Inst; 1977 May; 58(5):1407-12. PubMed ID: 67213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the cell-mediated immune response to murine sarcoma virus by (125I)iododeoxyuridine assay and comparison with chromium 51 and microcytotoxicity assays.
    Fossati G; Holden HT; Herberman RB
    Cancer Res; 1975 Sep; 35(9):2600-8. PubMed ID: 167966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simplified 51Cr-release assay for killer cells.
    Thorn RM; Palmer JC; Manson LA
    J Immunol Methods; 1974 Mar; 4(2):301-15. PubMed ID: 4546189
    [No Abstract]   [Full Text] [Related]  

  • 31. Specific inactivation of cytotoxic lymphocytes after adsorption on 51Cr-labeled fibroblast monolayers.
    Ritter J; Lohmann-Matthes ML; Fischer H
    Transplantation; 1973 Dec; 16(6):579-82. PubMed ID: 4148250
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of Tumor-like assay conditions, lonizing radiation, and hyperthermia on immune lysis of tumor cells by cytotoxic T-lymphocytes.
    Harris JW
    Cancer Res; 1976 Aug; 36(8):2733-9. PubMed ID: 6145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interruption of the sequential release of small and large molecules from tumor cells by low temperature during cytolysis mediated by immune T-cells or complement.
    Martz E; Burakoff SJ; Benacerraf B
    Proc Natl Acad Sci U S A; 1974 Jan; 71(1):177-81. PubMed ID: 4359327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of 125I-iododeoxyuridine as a cellular label for in vitro assays: kinetics of incorporation and toxicity.
    Le Mevel BP; Oldham RK; Wells SA; Herberman RB
    J Natl Cancer Inst; 1973 Nov; 51(5):1551-8. PubMed ID: 4797027
    [No Abstract]   [Full Text] [Related]  

  • 35. Specific reversal of cytolytic T lymphocyte--target cell interaction.
    Balk SP; Mescher MF
    J Supramol Struct Cell Biochem; 1981; 16(1):43-52. PubMed ID: 6795359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of iron-deficiency anemia on cytolytic activity of mice spleen and peritoneal cells against allogenic tumor cells.
    Kuvibidila SR; Baliga BS; Suskind RM
    Am J Clin Nutr; 1983 Aug; 38(2):238-44. PubMed ID: 6410896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined cytolytic effect of x irradiation and cell-mediated immune reactions on tumor cells in vitro.
    Song CW; Levitt SH
    Radiology; 1974 Apr; 111(1):211-2. PubMed ID: 4205812
    [No Abstract]   [Full Text] [Related]  

  • 38. Macrophage cytotoxicity in the mouse immune response against a skin allograft.
    Dimitriu A; Dy M; Thomson N; Hamburger J
    J Immunol; 1975 Jan; 114(1 Pt 1):195-9. PubMed ID: 122985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A radio (51Cr) micro-tube leukocyte adherence inhibition assay: specific tumor-associated immunity in 3 murine tumor systems.
    Russo AJ; Nordin AA; Goldrosen MH
    J Immunol Methods; 1979; 31(3-4):259-69. PubMed ID: 118217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An isotope-release assay and terminal-labeling assay for measuring cell-mediated allograft and tumor immunity to small numbers of adherent target cells.
    Tamerius JD; Garrigues HJ; Hellström I; Hellström KE
    J Immunol Methods; 1978; 22(1-2):1-22. PubMed ID: 78950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.